Bukhari Sumera, Taboada Javier
Internal Medicine, Seton Hall University-St. Francis Medical Center, Trenton, NJ.
Neurology, Seton Hall University-St. Francis Medical Center, Trenton, NJ.
Cureus. 2017 Feb 22;9(2):e1048. doi: 10.7759/cureus.1048.
Miller Fisher syndrome (MFS) was first recognized by James Collier in 1932 as a clinical triad of ataxia, areflexia, and ophthalmoplegia. Later, it was described in 1956 by Charles Miller Fisher as a possible variant of Guillain-Barré syndrome (GBS). Here, we write a case of a patient with atypical presentation of this clinical triad as the patient presented with double vision initially due to unilateral ocular involvement that progressed to bilateral ophthalmoplegia. He developed weakness of the lower extremities and areflexia subsequently. A diagnosis of MFS was made due to the clinical presentation and the presence of albuminocytologic dissociation in the cerebrospinal fluid (CSF) along with normal results of brain imaging and blood workup. The patient received intravenous immune globulin (IVIG), and his symptoms improved. The initial diagnosis of MFS is based on the clinical presentation and is confirmed by cerebral spinal fluid analysis and clinical neurophysiology studies. This case which emphasizes the knowledge of a rare syndrome can help narrow down the differentials to act promptly and appropriately manage such patients.
1932年,詹姆斯·科利尔首次将米勒·费希尔综合征(MFS)识别为一种由共济失调、腱反射消失和眼肌麻痹组成的临床三联征。后来,查尔斯·米勒·费希尔在1956年将其描述为吉兰-巴雷综合征(GBS)的一种可能变体。在此,我们报告一例该临床三联征非典型表现的患者,该患者最初因单侧眼部受累出现复视,随后发展为双侧眼肌麻痹。他随后出现下肢无力和腱反射消失。根据临床表现、脑脊液(CSF)中存在蛋白细胞分离以及脑成像和血液检查结果正常,诊断为MFS。患者接受了静脉注射免疫球蛋白(IVIG)治疗,症状有所改善。MFS的初步诊断基于临床表现,并通过脑脊液分析和临床神经生理学研究得到证实。这个强调对罕见综合征认识的病例有助于缩小鉴别诊断范围,以便迅速、适当地处理此类患者。